IL123258A - PEPTIDES SELECTIVE FOR mu-OPIOID RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME - Google Patents

PEPTIDES SELECTIVE FOR mu-OPIOID RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Info

Publication number
IL123258A
IL123258A IL12325896A IL12325896A IL123258A IL 123258 A IL123258 A IL 123258A IL 12325896 A IL12325896 A IL 12325896A IL 12325896 A IL12325896 A IL 12325896A IL 123258 A IL123258 A IL 123258A
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
opioid receptors
peptides selective
Prior art date
Application number
IL12325896A
Other languages
English (en)
Other versions
IL123258A0 (en
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9502877A external-priority patent/SE9502877D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL123258A0 publication Critical patent/IL123258A0/xx
Publication of IL123258A publication Critical patent/IL123258A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12325896A 1995-08-18 1996-08-14 PEPTIDES SELECTIVE FOR mu-OPIOID RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME IL123258A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9502877A SE9502877D0 (sv) 1995-08-18 1995-08-18 Novel opioid peptides
SE9503924A SE9503924D0 (sv) 1995-08-18 1995-11-07 Novel opioid peptides
PCT/SE1996/001011 WO1997007130A1 (en) 1995-08-18 1996-08-14 Novel opioid peptides

Publications (2)

Publication Number Publication Date
IL123258A0 IL123258A0 (en) 1998-09-24
IL123258A true IL123258A (en) 2003-03-12

Family

ID=26662362

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12325896A IL123258A (en) 1995-08-18 1996-08-14 PEPTIDES SELECTIVE FOR mu-OPIOID RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Country Status (27)

Country Link
US (1) US6337319B1 (xx)
EP (1) EP0845003B1 (xx)
JP (1) JPH11512086A (xx)
KR (1) KR19990037677A (xx)
CN (1) CN1200127A (xx)
AR (1) AR003475A1 (xx)
AT (1) ATE210148T1 (xx)
AU (1) AU711862B2 (xx)
BR (1) BR9610248A (xx)
CA (1) CA2229797A1 (xx)
CZ (1) CZ287299B6 (xx)
DE (1) DE69617699T2 (xx)
DK (1) DK0845003T3 (xx)
EE (1) EE9800048A (xx)
ES (1) ES2171224T3 (xx)
HU (1) HUP9901209A3 (xx)
IL (1) IL123258A (xx)
IS (1) IS4664A (xx)
NO (1) NO980592L (xx)
NZ (1) NZ315809A (xx)
PL (1) PL325113A1 (xx)
RU (1) RU2165432C2 (xx)
SE (1) SE9503924D0 (xx)
SK (1) SK282469B6 (xx)
TR (1) TR199800258T1 (xx)
TW (1) TW424095B (xx)
WO (1) WO1997007130A1 (xx)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030032774A1 (en) * 1994-02-21 2003-02-13 Astrazeneca Ab Novel opioid peptides for the treatment of pain
US5885958A (en) 1997-03-25 1999-03-23 Administrators Of The Tulane Educational Fund Mu-opiate receptor peptides
SE9701718D0 (sv) * 1997-05-07 1997-05-07 Astra Ab Analgesic peptidomimetic compounds
SE9800865D0 (sv) * 1998-03-16 1998-03-16 Astra Ab New Process
AU6730500A (en) * 1999-08-25 2001-03-19 Daiichi Fine Chemical Co., Ltd. Medicinal composition for percutaneous/permucosal absorption
AU1623801A (en) 1999-11-19 2001-05-30 Palatin Technologies, Inc. Opioid metallopeptide compositions and methods
US7498297B2 (en) 2000-07-18 2009-03-03 Cornell Research Foundation Medicinal uses of mu-opioid receptor agonists
JP2002069059A (ja) * 2000-08-28 2002-03-08 Teikoku Seiyaku Co Ltd ピラジノン環を含む新規なオピオイドペプチド誘導体
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (de) * 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
JP2008514612A (ja) * 2004-09-23 2008-05-08 ミシャロウ、アレクサンダー 対抗適応を誘発することにより神経伝達物質系を調節する方法
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
WO2006132925A2 (en) * 2005-06-01 2006-12-14 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy
EP1782819A1 (en) 2005-11-03 2007-05-09 Cognis IP Management GmbH Oligopeptides and their use
US7713937B2 (en) 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
BRPI0718651B8 (pt) 2006-11-10 2021-05-25 Cara Therapeutics Inc amidas peptídicas sintéticas
US8906859B2 (en) 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US8236766B2 (en) 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
TWI454288B (zh) 2008-01-25 2014-10-01 Gruenenthal Chemie 藥物劑型
PT2273983T (pt) * 2008-05-09 2016-10-28 Gruenenthal Gmbh Processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob utilização de uma etapa de congelamento por atomização
ES2560210T3 (es) * 2009-07-22 2016-02-17 Grünenthal GmbH Forma de dosificación resistente a la manipulación para opiádes sensibles a la oxidación
CN102573805A (zh) 2009-07-22 2012-07-11 格吕伦塔尔有限公司 热熔挤出的控制释放剂型
CN102821757B (zh) * 2010-02-03 2016-01-20 格吕伦塔尔有限公司 通过挤出机制备粉末状药物组合物
US20160176930A1 (en) 2010-07-09 2016-06-23 The Administrators Of The Tulane Educational Fund Mu opioid receptor agonist analogs of the endomorphins
TWI516286B (zh) 2010-09-02 2016-01-11 歌林達股份有限公司 含陰離子聚合物之抗破碎劑型
RU2604676C2 (ru) 2010-09-02 2016-12-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль
LT2736495T (lt) 2011-07-29 2017-11-10 Grünenthal GmbH Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu
CN103857386A (zh) 2011-07-29 2014-06-11 格吕伦塔尔有限公司 提供药物立即释放的抗破碎片剂
JP6117249B2 (ja) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
CA2868142A1 (en) 2012-04-18 2013-10-24 Grunenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CN102964279B (zh) * 2012-12-12 2014-05-07 中国药科大学 一类具有外周镇痛作用的κ阿片受体激动剂
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング １個または複数の粒子を含有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
CN105682643B (zh) 2013-07-12 2019-12-13 格吕伦塔尔有限公司 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
AU2014356581C1 (en) 2013-11-26 2020-05-28 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
US9872835B2 (en) 2014-05-26 2018-01-23 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
CN107889459A (zh) 2015-04-24 2018-04-06 格吕伦塔尔有限公司 具有立即释放和对溶剂萃取的抗性的抗篡改剂型
EP3346991A1 (en) 2015-09-10 2018-07-18 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0350221B1 (en) * 1988-06-30 1996-04-17 Astra Aktiebolag Dermorphin analogs, their methods of preparation, pharmaceutical compositions, and methods of therapeutic treatment using the same
IS4261A (is) * 1994-02-21 1995-08-22 Astra Aktiebolag Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra

Also Published As

Publication number Publication date
TR199800258T1 (xx) 1998-05-21
AU6760096A (en) 1997-03-12
NO980592D0 (no) 1998-02-11
ATE210148T1 (de) 2001-12-15
SK282469B6 (sk) 2002-02-05
HUP9901209A3 (en) 2000-12-28
SK20398A3 (en) 1998-12-02
EE9800048A (et) 1998-08-17
IL123258A0 (en) 1998-09-24
JPH11512086A (ja) 1999-10-19
KR19990037677A (ko) 1999-05-25
SE9503924D0 (sv) 1995-11-07
EP0845003A1 (en) 1998-06-03
PL325113A1 (en) 1998-07-06
WO1997007130A1 (en) 1997-02-27
NO980592L (no) 1998-02-11
CA2229797A1 (en) 1997-02-27
CN1200127A (zh) 1998-11-25
RU2165432C2 (ru) 2001-04-20
AU711862B2 (en) 1999-10-21
CZ287299B6 (en) 2000-10-11
ES2171224T3 (es) 2002-09-01
TW424095B (en) 2001-03-01
IS4664A (is) 1998-02-04
US6337319B1 (en) 2002-01-08
DK0845003T3 (da) 2002-07-15
BR9610248A (pt) 1999-07-06
AR003475A1 (es) 1998-08-05
DE69617699D1 (de) 2002-01-17
DE69617699T2 (de) 2003-08-07
HUP9901209A2 (hu) 1999-08-30
NZ315809A (en) 1999-05-28
CZ40198A3 (cs) 1998-08-12
EP0845003B1 (en) 2001-12-05

Similar Documents

Publication Publication Date Title
IL123258A (en) PEPTIDES SELECTIVE FOR mu-OPIOID RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL116211A0 (en) Peptide compounds pharmaceutical compositions containing the same and processes for the preparation thereof
IL115484A (en) Polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
HU9601698D0 (en) Pharmaceutical composition
IL106600A0 (en) Peptides,pharmaceutical compositions containing the same and processes for the preparation thereof
IL128058A0 (en) Illudin analogs and pharmaceutical compositions containing the same
IL114407A0 (en) Novel peptides and pharmaceutical compositions comprising them
GB9519667D0 (en) Pharmaceutical composition
ZA963590B (en) Pharmaceutical composition
IL114673A0 (en) Pharmaceutical compositions containing protein
GB9504761D0 (en) Amphiphilic peptide and analogs thereof
ZA9610426B (en) Pharmaceutical composition
ZA961051B (en) Pharmaceutical composition
ZA964193B (en) Pharmaceutical composition
HUP9602822A2 (en) Pharmaceutical composition
IL116976A0 (en) Synthetic peptides and pharmaceutical compositions comprising them
ZA963591B (en) Pharmaceutical composition
HU00563A9 (en) Pharmaceutical bacteriocin compositions and methods for using the same
HU00561A9 (en) Pharmaceutical bacteriocin compositions and methods for using the same
HUP9602732A3 (en) Pharmaceutical composition comprising lanperisone
IL112094A0 (en) Novel peptides and pharmaceutical compositions comprising them
ZA95736B (en) Pharmaceutical composition
IL115773A0 (en) Pharmaceutical compositions comprising peptides and some novel peptides
ZA96741B (en) Peptide a method for its preparation and a pharmaceutical composition containing the peptide

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees